PerspectiveCancer Genomics

Understanding the Enemy

See allHide authors and affiliations

Science Translational Medicine  31 Aug 2011:
Vol. 3, Issue 98, pp. 98ps37
DOI: 10.1126/scitranslmed.3003001

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


In this issue of Science Translational Medicine, Tanas and colleagues describe a disease-defining genetic alteration for the vascular cancer epithelioid hemangioendothelioma (EHE). The resulting EHE-associated fusion gene encodes an aberrantly expressed putative transcription factor. This molecular information is the latest in a series of genetic discoveries that aid in cancer diagnosis and may pave the way to targeted therapeutic agents.


  • Citation: V. E. Velculescu, L. A. Diaz Jr., Understanding the Enemy. Sci. Transl. Med. 3, 98ps37 (2011).

View Full Text

Stay Connected to Science Translational Medicine